Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
0.1944
-0.0357 (-15.51%)
At close: Nov 18, 2026, 4:00 PM EST
0.1944
0.00 (0.00%)
Pre-market: Nov 19, 2026, 7:20 AM EST
Acumen Pharmaceuticals Stock Forecast
ABOS's stock price has decreased by -87.7% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Acumen Pharmaceuticals stock have an average target of $1.00, which predicts a 414.40% increase from the current stock price of 0.19.
Price Target: $1.00 (+414.40%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Acumen Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lucid Capital | Lucid Capital | Hold Downgrades $7 → $1 | Hold | Downgrades | $7 → $1 | +414.40% | Nov 2, 2026 |
| BTIG | BTIG | Buy Maintains $8 → $1 | Buy | Maintains | $8 → $1 | +414.40% | Nov 2, 2026 |
| Citi | Citi | Hold Downgrades $5 → $1 | Hold | Downgrades | $5 → $1 | +414.40% | Nov 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Sell Downgrades n/a | Sell | Downgrades | n/a | n/a | Oct 30, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Downgrades $8 → $1 | Sell | Downgrades | $8 → $1 | +414.40% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.61
from -2.00
EPS Next Year
-0.49
from -1.61
EPS and Forward PE are based on non-GAAP adjusted numbers.